The explants were encapsulated in 250 µL of 4
different 1.5% (w/v) NaAlg solutions using a micropipette
(1000 µL) with a cut tip as follows: NaAlg as a control
group, NaAlg together with LS medium with or without
3% (w/v) sucrose, and NaAlg matrix augmented with LS
medium, 3% (w/v) sucrose, and 0.5 mg/L abscisic acid
(ABA)